| Lung Cancer |
0 |
0.99 |
| Brain Metastasis |
0 |
0.98 |
| Metastasis |
0 |
0.97 |
| Brain |
0 |
0.96 |
| Non-Small Cell Lung Cancer |
0 |
1 |
| Toxicology |
0 |
0.31 |
| Biologic Therapy |
0 |
0.26 |
| Thrombocytopenia |
0 |
0.26 |
| Chemotherapy |
0 |
0.24 |
| Small Cell Lung Cancer |
0 |
0.24 |
| Genomic Medicine |
0 |
0.22 |
| Cancer |
0 |
0.21 |
| Clinical Research |
0 |
0.17 |
| Lung |
0 |
0.17 |
| HIV Infection |
0 |
0.12 |
| Corticosteroids |
0 |
0.1 |
| Pain Management |
0 |
0.1 |
| Anaplastic Lymphoma Kinase |
0 |
0.08 |
| Central Nervous System |
0 |
0.07 |
| Back Pain |
0 |
0.06 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.04 |
| Neutropenia |
0 |
0.04 |
| Aminotransferase |
0 |
0.03 |
| Anemia |
0 |
0.03 |
| Blood |
0 |
0.03 |
| Board Certification |
0 |
0.03 |
| Brachial |
0 |
0.03 |
| Dorsum |
0 |
0.03 |
| Dyspnea |
0 |
0.03 |
| Epidermal Growth Factor Receptor |
0 |
0.03 |
| Hallucination |
0 |
0.03 |
| Immunotherapy |
0 |
0.03 |
| Lymphoma |
0 |
0.03 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.03 |
| Pain |
0 |
0.03 |
| Prognosis |
0 |
0.03 |
| Quality of Life |
0 |
0.03 |
| Steroids |
0 |
0.03 |
| Transplant Evaluation |
0 |
0.03 |